СОВРЕМЕННЫЕ АСПЕКТЫ ПАТОГЕНЕТИЧЕСКИХ МЕХАНИЗМОВ ГЛОМЕРУЛОПАТИЙ У ДЕТЕЙ

Амонов Р.А. Бухарский государственный медицинский институт

Резюме

В настоящем обзоре представлены современные исследования зарубежных авторов, раскрывающие иммунные аспекты патогенеза заболеваний клубочкового аппарата почек у детей. Автором обобщены и систематизированы наиболее значимые иммунологические факторы, участвующие в формировании гломерулопатий у детей.

Ключевые слова: дети, гломерулопатия, гломерулонефрит, иммунная система, патогенез

Первая страница
66

Последняя страница
70

Для цитирования

Амонов Р.А.СОВРЕМЕННЫЕ АСПЕКТЫ ПАТОГЕНЕТИЧЕСКИХ МЕХАНИЗМОВ ГЛОМЕРУЛОПАТИЙ У ДЕТЕЙ// Евразийский вестник педиатрии. — 2021; 3 (10): 66-70. https://cutt.ly/5RNDCdT

Литература

  1. 1. Zhiznevskaya I.I., Khmelevskaya I.G., Razin’kova N.S., Minenkova T.A., Yakovleva A.V. Osobennosti immunnogo statusa u detey s ostrymi i khronicheskimi glomerulopatiyami. Kurskiy nauchno-prakticheskiy vestnik «Chelovek i yego zdorov’ye». – 2017. – № 4.S42-45
  2. 2. Ignatova Mayya Sergeyevna (2011). Glomerulopatii u detey. Pediatriya. Zhurnal im. G. N. Speranskogo, 90 (3), 125-128.
  3. 3. Novakova O.N., Nekipelova Ye.V. Sovremennyye predstavleniya ob etiopatogeneze khronicheskogo glomerulonefrita i rol’ geneticheskikh faktorov v yego formirovanii nauchnyye //Vedomosti Seriya Meditsina. Farmatsiya. 2014. № 4 (175). Vypusk 25, s 172-176
  4. 4. Sivtseva Ye.M., Dlin V.V., Vozdvizhenskaya Ye.S. Klinicheskoye znacheniye opredeleniya urovnya endotelina-1 v plazme krovi u detey s nefroticheskim sindromom pri glomerulonefrite. Rossiyskiy vestnik perinatologii i pediatrii, 5, 2012, S29-35
  5. 5. Khmelevskaya I.G., Zhiznevskaya I.I., Razin’kova N.S.  Prognosticheskoye znacheniye immunologicheskikh pokazateley pri glomerulonefritakh u detey nauchnyye //Vedomosti Seriya Meditsina. Farmatsiya. 2014. № 24 (195). Vypusk 28/1 S 56-59
  6. 6. Carlsson AC, Östgren CJ, Länne T, Larsson A, Nystrom FH, Ärnlöv J. The association between endostatin and kidney disease and mortality in patients with type 2 diabetes. Diabetes Metab. 2016;42(5):351–7. 10.1016/j.diabet.2016.03.006 [PubMed] [CrossRef] [Google Scholar]
  7. 7. Jacob A, Chaves L, Eadon MT, Chang A, Quigg RJ, Alexander JJ. Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice. Immunology. 2013;139(3):328-337. doi:10.1111/imm.12079
  8. 8. Janssen WJ, Henson PM. Cellular regulation of the inflammatory response. Toxicol Pathol. 2012;40:166–73. [PMC free article] [PubMed] [Google Scholar]
  9. 9. Kupin WL. Viral-Associated GN: Hepatitis C and HIV. Clin J Am Soc Nephrol. 2017;12(8):1337-1342. doi:10.2215/CJN.04320416
  10. 10. Li J, Liu CH, Xu DL, Gao B. Significance of CD163-Positive Macrophages in Proliferative Glomerulonephritis. Am J Med Sci. 2015;350(5):387-392. doi:10.1097/MAJ.0000000000000569
  11. 11. Lin CHS, Chen J, Zhang Z, Johnson GVW, Cooper AJL, Feola J, et al. Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. Kidney Int.2016;89(6):1281–92. 10.1016/j.kint.2016.01.030 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  12. 12. Loof T, Krämer S, Gaedeke J, Neumayer HH, Peters H. IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis. PLoS One. 2016;11(5):e0156480. Published 2016 May 31. doi:10.1371/journal.pone.0156480
  13. 13. Mårtensson J, Jonsson N, Glassford NJ, Bell M, Martling C-R, Bellomo R, et al. Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients. Ann Intensive Care. 2016;6(1):6 10.1186/s13613-016-0108-x [PMC free article] [PubMed] [CrossRef] [Google Scholar
  14. 14. O′Sullivan KM, Lo CY, Summers SA, Elgass KD, McMillan PJ, et al. (2015) Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Kidney Int 88: 1030–1046. doi: 10.1038/ki.2015.202 [PubMed] [Google Scholar]
  15. 15. Pena MJ, de Zeeuw D, Mischak H, Jankowski J, Oberbauer R, Woloszczuk W, et al. Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes. Nephrol Dial Transplant. 2015;30 Suppl 4:iv86–95. [PubMed] [Google Scholar]
  16. 16. Prasad N, Novak JE, Patel MR. Kidney Diseases Associated With Parvovirus B19, Hanta, Ebola, and Dengue Virus Infection: A Brief Review. Adv Chronic Kidney Dis. 2019;26(3):207-219. doi:10.1053/j.ackd.2019.01.006
  17. 17. Ruge T, Carlsson AC, Larsson TE, Carrero J-J, Larsson A, Lind L, et al. Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts. Am J Nephrol. 2014;40(5):417–24. 10.1159/000369076 [PubMed] [CrossRef] [Google Scholar]
  18. 18. Sun LJ, Shan JP, Cui RL, Yuan WJ, Jiang GR. Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases. Int Urol Nephrol. 2017;49(6):1049-1056. doi:10.1007/s11255-017-1563-5
  19. 19. Wallwitz J, Aigner P, Gadermaier E, et al. Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis. PLoS One. 2019;14(8):e0220935. Published 2019 Aug 12. doi:10.1371/journal.pone.0220935

Статья доступна ниже:

Скачать PDF